UBS Raises Micron Price Target Amid Sustained Chip Shortage Forecast

Despite reaching a fresh peak this week, Micron Technology’s shares faced downward pressure in Thursday’s trading, influenced by broader sector weakness rather than company-specific news. While near-term profit-taking and tech stock volatility are applying brakes, major investment firms are turning bullish, adjusting their price targets upward. The focus for these institutions is not the current pullback but the prospect of a prolonged supply crunch in the memory chip market.

Institutional Buying Contrasts with Insider Sales

Beneath the daily price swings, significant shifts are occurring in the shareholder register. Recent filings reveal that institutional investors are expanding their stakes.

• UBS Asset Management (OCONNOR): This entity purchased approximately 20,000 Micron shares during the second quarter of 2025.
• Slate Path Capital LP: The fund established a new position valued at roughly $317.75 million.

Institutions now collectively hold over 80% of the company’s freely tradable shares, indicating sustained interest from major players.

Conversely, corporate insiders have recently been net sellers. Over the past three months, insiders disposed of about 392,352 shares worth approximately $83 million. These transactions are largely viewed as profit-taking at significantly elevated price levels. Market participants monitor such activity closely, as it can serve as a sentiment indicator following a substantial rally.

UBS Analyst Lifts Target on Structural Supply Thesis

A new research note from UBS is central to the optimistic narrative. On Thursday, analyst Timothy Arcuri reaffirmed his “Buy” rating on Micron and increased his 12-month price target from $275 to $295 per share. This new target implies an upside potential of roughly 12% from current levels.

The rationale for the upgrade hinges on a forecast of structural undersupply in the memory chip market, from which Micron is positioned to benefit. UBS highlights two key segments:

• DRAM: The bank anticipates supply constraints will persist through the first quarter of 2027.
• NAND: A supply shortage is also expected in this segment, likely lasting until the fourth quarter of 2026.

Arcuri argues that this supply deficit will create sustained upward pricing pressure. Higher selling prices should translate directly into improved margins for Micron, forming the core driver behind the raised valuation.

High Stakes for Upcoming Earnings Report

The market is now looking ahead to the next major catalyst: Micron’s earnings release for its fiscal first quarter, scheduled for after the U.S. market close on December 17, 2025. Expectations are running high, and the report is likely to set the tone for the stock’s trajectory heading into 2026.

Should investors sell immediately? Or is it worth buying Micron?

Current estimates point to robust growth:

• Revenue: UBS projects sales of $13.2 billion. The Wall Street consensus is slightly more conservative at around $12.78 billion. Either figure would represent a year-over-year increase of approximately 45%.
• Earnings Per Share (EPS): The analyst consensus expects EPS of about $3.90. UBS is notably more optimistic, forecasting $4.27 per share. This compares to just $1.79 per share in the same quarter last year.
• Long-Term View: Looking further ahead, UBS models that an EPS approaching $38 could be achievable for the full 2027 fiscal year, fueled by a continuing investment cycle in artificial intelligence infrastructure.

The bar for the upcoming report is clearly set at a lofty level. Positive results could provide further momentum for bullish scenarios, while any disappointment may quickly weigh on the share price.

Sector-Wide Pressure from Oracle Weighs on Sentiment

Despite the favorable analyst coverage, Micron’s stock traded lower on Thursday. The pressure originated not from Micron-specific news but from weakness in the broader technology sector. Oracle shares sold off sharply after the software giant reported disappointing revenue and higher-than-anticipated capital expenditure (CapEx).

This news dampened sentiment across AI-related stocks. Shares of companies like Nvidia and Micron were pulled lower in early trading alongside Oracle, shedding between 1% and 3%. Investors are reacting sensitively to Oracle’s elevated spending plans, concerned that returns on major AI infrastructure projects may materialize more slowly than previously hoped. This concern is temporarily affecting sentiment across the semiconductor space.

Technical and Analyst Consensus Overview

From a chart perspective, Micron is coming off an exceptionally strong year, with its shares having advanced over 155% since January. The stock hit a new 52-week high of 225.55 euros on Wednesday before retreating about 3.7% to 217.20 euros on Thursday. Even with this dip, the shares remain well above key moving averages, trading roughly 11% above the 50-day average.

The analyst community remains overwhelmingly positive:

• HSBC: Initiated coverage this week with a “Buy” recommendation and a $330 price target.
• Citi: Reiterated its “Buy” rating with a $300 target on December 10.
• Overall Consensus: Currently, 40 out of 46 analysts rate the stock as a “Buy” or “Strong Buy.”

Volatility is expected to remain elevated as the December 17 earnings date approaches. Micron shares will continue to find their new equilibrium in the tension between the structurally positive outlook from major banks like UBS and short-term headwinds emanating from the tech sector.